Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules

Crimean-Congo hemorrhagic virus (CCHFV) causes hemorrhagic fever with high case mortality rates and is endemic in south-eastern Europe, Africa, and Asia. The limited catalog of specific treatment, highlight the necessity to look for additional therapeutic solutions. Previous experiments suggested th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraris, O., Moroso, M., Pernet, O., Emonet, S., Ferrier Rembert, A., Paranhos-Baccalà, G., Peyrefitte, C.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113845/
https://www.ncbi.nlm.nih.gov/pubmed/25796972
http://dx.doi.org/10.1016/j.antiviral.2015.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113845/
https://www.ncbi.nlm.nih.gov/pubmed/25796972
http://dx.doi.org/10.1016/j.antiviral.2015.03.005

Ejemplares similares